The short version of hGH fragment fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-04-17. Anything still debated is marked as such rather than presented as settled.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
| Property | Value | Notes |
|---|---|---|
| Common synonym | hGH fragment 176-191 | Refers to the C-terminal segment |
| Appearance | White to off-white powder | Typically supplied lyophilized |
| Solubility | Soluble in water and aqueous buffers | Confirm with technical data |
| Typical storage temperature | -20 °C for dry powder | Protect from moisture and light |
| Common analytical method | RP-HPLC with UV detection | Often paired with mass spectrometry |
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
One of the important factors in determining the dentinal bonding is collagen. When dentin is etched, smear layer and minerals from dentinal structure will be removed, hence exposing the collagen fibres. The areas where the minerals are removed are filled with water which functions as plasticizer for collagen and keeps it at expanded soft state. This means that the spaces for resin-dentin bonding are preserved. However, these collagen fibres can collapse in dry condition and if the organic layer of matrix is denatured, this will obstruct the resin to bond with dentin and form a hybrid layer. Because of this, the presence of moist or wet dentin is required to achieve successful dentin bonding. This is due to presence of water miscible organic solvents like ethanol or acetone in the primers. The acetone trails water and hence improves the penetration of the monomers into the dentin for better micromechanical bonding. Also, water will prevent collagen fibres from collapsing, thus making better penetration and bonding between resin and dentin.
Penicillins (P, PCN or PEN) are a group of β-lactam antibiotics originally obtained from Penicillium moulds, principally P. chrysogenum and P. rubens. Eight species of Penicillium, in the section Chrysogena, produce penicillins. Most penicillins in clinical use are synthesised by P. chrysogenum using deep tank fermentation and then purified. A number of natural penicillins have been discovered, but only two purified compounds are in clinical use: penicillin G (intramuscular or intravenous use) and penicillin V (given by mouth). Penicillins were among the first medications to be effective against many bacterial infections caused by staphylococci and streptococci. They are still widely used today for various bacterial infections, though many types of bacteria have developed resistance following extensive use. In the United States, 10% of the population claims penicillin allergies, but because the frequency of positive skin test results decreases by 10% with each year of avoidance, 90% of these patients can eventually tolerate penicillin. Additionally, those with penicillin allergies can usually tolerate cephalosporins (another group of β-lactam) because the immunoglobulin E (IgE) cross-reactivity is only 3%. Penicillin was discovered in 1928 by the Scottish physician Alexander Fleming as a crude extract of P. rubens. Fleming's student Cecil George Paine was the first to successfully use penicillin to treat eye infection (neonatal conjunctivitis) in 1930.
Peukert argued that the creation of the Weimar welfare state in the 1920s had "politicized" economic and social relationships, and in the context of the Great Depression where economic resources were shrinking set off a Darwinian struggle for scare economic resources between various societal groups. Peukert wrote by 1930 German society had with the notable exceptions of the working class and the Catholic milieus had turned into a mass of competing social interests engaged in a Darwinian verteilungskampf (distribution struggle). In this context, Peukert argued that for much of German society, some sort of authoritarian government was welcome out of the belief that an authoritarian regime would favor one's own special interest group at the expense of the others. Given the verteilungskampf, Peukert argued that this explain why the "presidential governments"-which from March 1930 onward by-passed the Reichstag and that answered only to President Paul von Hindenburg-governing Germany in a highly authoritarian manner were so approved of by German elites. Peukert further maintained that the Hitler government of 1933, which was the last of the "presidential governments" was merely the final attempt by traditional elites in Germany to safeguard their status. Peukert insisted that National Socialism was not some retrogression to the past, but instead reflected the "dark side" of modernity, writing: "The NSDAP was at once a symptom and a solution to the crisis".
Portable ultrasound is a low-cost tool to identify the sign of liver surface nodularity with good diagnostic accuracy. Cirrhosis is also diagnosable through a variety of new elastography techniques. When a liver becomes cirrhotic, it will generally become stiffer. Determining the stiffness through imaging can determine the location and severity of the disease. Techniques include transient elastography, acoustic radiation force impulse imaging, supersonic shear imaging and magnetic resonance elastography. Transient elastography and magnetic resonance elastography can help identify the stage of fibrosis. Compared to a biopsy, elastography can sample a much larger area and is painless. It shows a reasonable correlation with the severity of cirrhosis. Other modalities have been introduced, which are incorporated into ultrasonography systems. These include 2-dimensional shear wave elastography and point shear wave elastography which uses acoustic radiation force impulse imaging. Rarely are diseases of the bile ducts, such as primary sclerosing cholangitis, causes of cirrhosis. Imaging of the bile ducts, such as ERCP or MRCP (MRI of biliary tract and pancreas) may aid in the diagnosis.
In this method, polyvinylpyrrolidone (PVP) is dissolved in water by sonication and mixed with silver colloid particles. Active stirring ensures the PVP has adsorbed to the nanoparticle surface. Centrifuging separates the PVP coated nanoparticles which are then transferred to a solution of ethanol to be centrifuged further and placed in a solution of ammonia, ethanol and Si(OEt4) (TES). Stirring for twelve hours results in the silica shell being formed consisting of a surrounding layer of silicon oxide with an ether linkage available to add functionality. Varying the amount of TES allows for different thicknesses of shells formed. This technique is popular due to the ability to add a variety of functionality to the exposed silica surface.
Sources: en.wikipedia.org
Under the command of Bolívar and Sucre, the experienced veterans of the combined army, mainly Colombians, destroyed a royalist army under La Serna's command in the Battle of Ayacucho on 9 December 1824. La Serna's army was numerically superior but consisted of mostly new recruits. The only significant royalist area remaining on the continent was the highland country of Upper Peru. Following the Battle of Ayacucho, the royalist troops of Upper Peru under the command of Olañeta surrendered after he died in Tumusla on 2 April 1825. Bolívar tended to favor maintaining the unity of Upper Peru with Peru, but the Upper Peruvian leaders—many former royalists, like Casimiro Olañeta, nephew of General Olañeta—gathered in a congress under Sucre's auspices supported the country's independence. Bolívar left the decision to Sucre, who went along with the congress. Sucre proclaimed Upper Peru's independence in the city which now bears his name on 6 August, bringing the main wars of independence to an end. As it became clear that there was to be no reversal of Spanish American independence, several of the new states began to receive international recognition. Early, in 1822, the United States recognized Chile, the United Provinces of the Río de la Plata, Peru, Gran Colombia, and Mexico. Britain waited until 1825, after the Battle of Ayacucho, to recognize Mexico, Gran Colombia, and Río de la Plata. Both nations recognized more Spanish American states in the next few years.
== History == The name magnesium originates from the Greek word for locations related to the tribe of the Magnetes, either a district in Thessaly called Magnesia or Magnesia ad Sipylum, now in Turkey. It is related to magnetite and manganese, which also originated from this area, and required differentiation as separate substances. See the manganese article for this history. In 1618, a farmer at Epsom in England attempted to give his cows water from a local well. The cows refused to drink because of the water's bitter taste, but the farmer noticed that the water seemed to heal scratches and rashes. The substance obtained by evaporating the water became known as Epsom salts and its fame spread. It was eventually recognized as hydrated magnesium sulfate, MgSO4·7 H2O. The metal itself was first isolated by Sir Humphry Davy in England in 1808. He used electrolysis on a mixture of magnesia and mercuric oxide. Antoine Bussy prepared it in coherent form in 1831. Davy's first suggestion for a name was 'magnium', but the name magnesium is now used in most European languages. Further discoveries about magnesium were made by the father of physical chemistry in Imperial Russia, Nikolai Beketov (1827–1911), who established that magnesium and zinc displaced other metals from their salts under high temperatures.
== Cast == Toula Stathopoulou: Eleni Gousis Yannis Totsikas: Ranger Hristos Gikas Thanos Grammenos: Eleni's Brother Petros Hoedas: Investigator Mihalis Fotopoulos: Eleni's Husband Kostas Gousis Yannis Balaskas: Police Officer Nicos Alevras: Investigator's Assistant Alekos Alexiou: Police Officer Theo Angelopoulos, Christos Paliyannopoulos, Telis Samandas, Panos Papadopoulos, Adonis Lykouresis, Giorgos Arvanitis, Mersoula Kapsali: Journalists
Stanton became renowned around the AFL for his endurance and quickly established himself as one of the club's key players and most dangerous midfielders. He finished off an impressive season by finishing sixth in the 2007 Crichton Medal with 197 votes. In the 2008 pre-season, Stanton would be handed the number five guernsey, worn by retired club captain James Hird. Stanton struggled early in the season due to close checking from opposition players. Although he only averaged 22 possessions and kicked 18 goals in the season, his much-criticised tackling had improved vastly. Stanton finished third in the 2008 Crichton Medal, behind Matthew Lloyd and David Hille, with 188 votes. In 2009, Stanton was a significant player in an Essendon team which went through the home and away season with 10 wins, 11 defeats and a draw. He played every game in the home and away season in which they qualified in eighth position for the finals series, losing the First Elimination Final to Adelaide by 96 points. Stanton polled a career high eight votes in the Brownlow Medal and finished third in the 2009 Crichton Medal behind, Dustin Fletcher and Jobe Watson with 284 votes. Stanton played his 100th AFL game in round 2 against Fremantle.
== Members == Four members of 2A peptides family are frequently used in life science research. They are P2A, E2A, F2A, and T2A. F2A is derived from foot-and-mouth disease virus 18; E2A is derived from equine rhinitis A virus; P2A is derived from porcine teschovirus-1 2A; T2A is derived from thosea asigna virus 2A. The following table shows the sequences of four members of 2A peptides. Adding the optional linker “GSG” (Gly-Ser-Gly) on the N-terminal of a 2A peptide greatly helps with efficiency.
Sources: en.wikipedia.org
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.
No. It is a shortened peptide fragment, not the full hormone. It does not contain the entire hGH sequence and is studied for different proposed effects.
Regulatory approvals for weight loss are not established in major jurisdictions. Some human trials reported modest changes, but the evidence is limited, and it remains a research compound.
No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.